<< Low-profile balloon catheter for PAD launched | Two merge to form Jazz Pharmaceuticals >>

Sanofi in R&D deal for acne vaccine

by emma 21. September 2011 15:04

Sanofi Pasteur has signed a research and development agreement with the University of California, San Diego, for its experimental acne vaccine and treatment.

The R&D pact includes a two-year collaboration with Chun-Ming Huang and team at UC San Diego School of Medicine.

The team’s immunological approach to acne prevention and treatment targets the neutralisation of Propionibacterium inflammation.

Elias Zerhouni, President of Global Research and Development at Sanofi, said that the vaccine and treatment could address an unmet medical need.

“This investigational vaccine and treatment may lead to a better solution for the many who suffer from this skin disease,” said Mr Zerhouni.

According to the vaccine division of Sanofi, the annual market for acne therapeutics is in excess of $3 billion.

8307375b-38af-4e36-aa81-8b55c2b7c0ea|0|.0

Tags: Sanofi, Sanofi Pasteur, R&D, research, development, research and development, agreement, deal, pact, collaboration, collaborate, acne, vaccine, vaccinate, vaccination, vaccinations, experimental, treatment, therapy, cure, Chun Ming Huang, Chun-Ming Huang, UC San Diego, School of Medicine, medicine, medication, medicines, medications, drug, drugs, pharma, pharmaceutical, pharmaceuticals, pharmafield, pharma field, pharmaceutical field, pharmaceuticalfield, pf, product news, pharma news uk, immunological, immunology, prevention, neutralise, neutral, neutralisation, propionibacterium, inflammation, inflame, inflamed, Elias Zerhouni, President, Global, medical, medical sale, medical sales, market, therapeutics

News

Sanofi Pasteur MSD executive to lead Vaccines EuropeAndrea Rappagliosi, Sanofi Pasteur MSD’s Vice President of Market Access, Health Policy & Medical Af...GSK and Merck accept cut-price vaccines dealGlaxoSmithKline (GSK) and Merck have agreed a deal to make their rotavirus vaccines available in the...Sanofi Pasteur submits vaccine application to FDASanofi Pasteur has submitted a supplemental application to the FDA for its influenza H1N1 monovalent...

Comments

11/14/2011 5:11:55 AM #

Nice publish i really like your writing style. Hi there what topic are you the use of is it a unfastened one i would like to take a look at it on my site.

cream for stretch marks

11/14/2011 6:41:18 AM #

Nice submit i really like your writing style. Whats up what topic are you the use of is it a loose one i would really like to take a look at it on my site.

stretch marks removal cream

11/14/2011 8:32:30 PM #

<a href="sitespin">anchorspin</a>

serobot review

11/23/2011 1:41:23 PM #

Your writing is great

Sona Gwynes

11/23/2011 1:53:59 PM #

Your writing is great

Kelley Dago

11/29/2011 7:22:42 AM #

Glamour post helps me. Oh

Silver Jewelry

12/2/2011 3:24:59 AM #

Just want to say your article is as astonishing. The clarity in your post is simply cool and i can assume you are an expert on this subject. Fine with your permission allow me to grab your feed to keep up to date with forthcoming post. Thanks a million and please continue the enjoyable work.

Sukienki

12/8/2011 1:22:16 AM #

I am rather thankful to you as regards posting such stuff.This surely help me lot.I remarkably prize your work.

Metodo Gabriel

12/30/2011 7:35:22 AM #

I dugg some of you post as I cerebrated they were very beneficial extremely helpful

ratownik medyczny

12/30/2011 7:41:08 AM #

But a smiling visitor here to share the love (:, btw outstanding style and design .

ratownik medyczny

1/4/2012 8:00:41 PM #